• Request sample

Global Bioimpedance Analyzers Market Overview

The Global Bioimpedance Analyzers market was valued at USD 472.10 million in 2023 and is expected to reach USD 1042.41 million by the year 2032, at a CAGR of 9.2%.

Bioimpedance Analyzers (BIA) are referred to as the screening tool that can be applied to measure and correctly analyze body composition and body fat. It is a non-invasive tool utilized by medical practitioners to measure the percentage of body fat. It also allows the estimation of the percentage of muscle tissues, percentage of hydration levels, metabolic rate, bone weight, and fitness levels. There are a variety of methods utilized for the clarification of measured bioimpedance data and an extensive range of applications of bioimpedance in body composition estimation. Bioimpedance Analyzers act on the principle of electrical conductivity. Bioimpedance Analyzers is rising in popularity owing to their convenience and the extensive range of parameters it can monitor. The test involves placing two electrodes on a person's right hand and foot. A low-level and imperceptible electrical current is sent via the body. The flow of the current through a patient's body is influenced by the amount of water composition. The device fundamentally measures how this signal is hampered through various kinds of tissue. The tissues that comprise large amounts of fluid and electrolytes, such as blood, generally have high conductivity. Additionally, fat and bone slow the signal down. Since Bioimpedance Analyzers is utilized to determine the resistance to flow of the current as it passes through the body, it can offer estimates of body water from which body fat is then calculated using specific tools. Many companies such as Zurich Instruments AG and Tanita produce the Bioimpedance Analyzers devices.

For instance, one of Tanita's flagship products, the BF679W, can be utilized to measure a patient's bio-impedance. This can then be applied for measuring muscle mass, body fat percentage, muscle quality, and visceral fat. Additionally, body composition analyzers can be used in different settings. Hospitals are one of the largest users of these devices. Parameters such as fat mass, muscle mass, and body water can be measured easily using these meters. The mBCA 525 meters were manufactured by Seca for exclusive utilization in hospitals where large data sets and Bluetooth and Wi-Fi connectivity are required in devices. Devices like these are anticipated to see increased demand due to their convenience.

Bioimpedance Analyzers Market 2024 - Global Demand & Analysis By 2032

Market Dynamics And Factors For The Bioimpedance Analyzers Market

Drivers:

Digitization in the Healthcare Industry

Companies are targeted on the advancement of products that provide economic as well as clinical relevance to the overall business. This can be attributed to factors such as the growth of the healthcare industry in emerging economies and investments in healthcare information technology by governments as well as public sector organizations. Furthermore, growing healthcare spending, coupled with efforts by producers to provide innovative bioimpedance analyzers to serve the rising demand for advanced solutions in emerging economies, is also expected to turn the growth of the bioimpedance analyzers market in the upcoming years.

Growing Frequency of Lifestyle Diseases

Unhealthy lifestyles, such as sedentary work environments, utilization of junk food, and increased mobility automation have increased the frequency of different lifestyle diseases, such as obesity, high blood pressure, and diabetes. As per the CDC (Centres for Disease Control and Prevention), the global prevalence of obesity climbed to 42.4% in 2019 from 30.5% in 2000. Obesity is now termed a global crisis; an estimated 57.8% of all adults are anticipated to be categorized as obese by 2030 (Source: WHO, 2020). Additionally emerged economies, obesity is now an epidemic in low- and middle-income economies as well. Bioimpedance analyzers provide an accurate measurement of the amount of fat, muscle, and bone in the human body. This will be accelerating the growth of the bioimpedance analyzers market over the forecast period.

Restraints:

Variability In the Accuracy of Several Bioimpedance Analyzers

Even though the technology is developing, it is difficult to get accurate body fat measurements from the most commercially accessible body fat analyzers. The working of analyzers comprises passing an electrical current that follows the path of least resistance through the body. As fat contains less water, the fat-free mass has the least resistance to electrical current. Nevertheless, a large amount of fat underneath the skin is not determined by these analyzers. Additionally, body immunity varies among different ethnic groups and influences the accuracy of body composition analyzers.

Opportunities:

Developing Market Across the Asia Pacific and Latin America

Developing countries such as India, China, and Brazil are anticipated to observe maximum expansions in the bioimpedance analyzers market. This can be attributed to the growing frequency of lifestyle diseases, rising consciousness regarding health and obesity, and infrastructural developments in these economies. China is an important market in this regard, given its recent infrastructural developments, rapid economic growth, growing domestic demand, and public-private initiatives to support healthcare research. China's State Council sanctioned the 2016–2020 National Fitness Plan, which has encouraged all national fitness levels and increased sports participation.

Market Segmentation

Segmentation Analysis of Bioimpedance Analyzers Market:

Based on Product Type, the bioimpedance analyzers market is segmented into Single-frequency Analyzers, Dual-frequency Analyzers, Multi-frequency Analyzers, Bioimpedance Spectroscopy, Whole Body Bioimpedance Measurement, Body Segment Bioimpedance Measurement, Alternative Bioimpedance Analysis Method. The Multi-frequency Analyzers segment is expected to witness the maximum growth during the forecast period. The preference for multi-frequency bioimpedance analyzers is high among end-users as they can be utilized for both segmental and whole-body measurement, far from the single-frequency bioimpedance analyzers.

Based on the Modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment accounted for the largest bioimpedance analyzers market during the forecast period. The developments in and the rising demand for wireless technologies are major turning factors for this bioimpedance analyzers market.

Based on End-Users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs, and wellness centers, home users, and other end users. The fitness clubs and wellness centers segment are expected to hold the maximum share of the bioimpedance analyzers market over the forecast period. The growing number of fitness clubs and wellness centers and the rising consciousness regarding health and fitness over the world are the key driving factor for this bioimpedance analyzers market.

Based on the Application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment is anticipated to register the highest bioimpedance analyzers market share throughout the projected period. The large share of this segment can be attributed to the rising prevalence of obesity and metabolic disorders.

Regional Analysis of Bioimpedance Analyzers Market:

Based on the region, the bioimpedance analyzers market is classified into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

The North American region is expected to dominate the bioimpedance analyzers market during the forecast period. The maximum share of North America can be attributed to factors such as the rising obesity rate, government initiatives to motivate healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and rising number of health clubs and fitness centers.

In the Asia Pacific, the growing number of Chinese players in the market is anticipated to boost the growth of the bioimpedance analyzers market in China. Similarly, other local producers in the Asia Pacific region are anticipated to support the growth of the bioimpedance analyzers market over the forecast period.

Players Covered in Bioimpedance Analyzers market are :

  •  Xiaomi (China)
  •  Guangzhou Beautylife Electronic Technology Co.Ltd. (China)
  •  Bodystat Ltd. (UK)
  •  InBody (South Korea)
  •  RJL Systems (US)
  •  seca GmbH & Co. KG (Germany)
  •  EVOLT 360 (Australia)
  •  Chartered Electronics Co. Ltd. (China)
  •  SELVAS Healthcare (South Korea)
  •  Akern (Italy)
  •  Maltron International (UK)
  •  Fook Tin Group Holding Ltd. (China)
  •  Biotekna (Italy)
  •  Withings (France)
  •  Omron Corporation (Japan)
  •  Biodynamics Corporation (US)
  •  Bioparhom (France)
  •  Tanita Corporation (Japan)
  •  Sino-Hero (Shenzhen)
  •  Bio-Medical Electronics Co.Ltd. (China)
  •  Lumsail Industrial Inc. (China)
  •  and others.

Key Industry Developments In The Bioimpedance Analyzers Market

  • In January 2016, Seca GmbH & co. kg, Hamburg, has presented a way to perform a mobile body composition analysis on patients in the supine position (Hall 12 at Stand 12 A 63). seca has made this a reality through a global innovation that ushers in a new era for lying bioimpedance measurement in terms of precision, medical validation, and handling. The seca mBCA 525 offers a complete analysis of body composition using medically validated data for diagnosis and therapy. The innovative centerpiece is a measuring mat as a multifunctional tool.
  • In 2017, Selvas Healthcare introduced the ACCUNIQ BC380 artificial intelligence-based body composition analyzer globally.
  • In July 2020, Omron Healthcare partnered with Mount Sinai Health System of New York to provide patients with its new VitalSight home blood pressure monitoring solution.
  • In January 2020, InBody USA introduced the InBody 970 device. The device utilizes novel technology to categorize and analyze abdominal fat and total body water.

Global Bioimpedance Analysers Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 472.10 Mn.

Forecast Period 2024-32 CAGR:

9.2%

Market Size in 2032:

USD 1042.41 Mn.

Segments Covered:

By Type

  • Single-frequency Analyzers
  • Dual-frequency Analyzers
  • Multi-frequency Analyzers

By Modality

  • Wireless Bioimpedance Analyzers
  • Wired Bioimpedance Analyzers

By Application

  • Segmental Body Measurement
  • Whole-body Measurement

By End Users

  • Hospitals
  • Fitness Clubs and Wellness Centers
  • Home Users
  • Other

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Frequency of Lifestyle Diseases

Key Market Restraints:

  • Variability in the Accuracy of Several Bioimpedance Analyzers

Key Opportunities:

  • Digitization in the Healthcare Industry

Companies Covered in the report:

  • Omron Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), Seca GmbH & Co. KG (Germany), and other major players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Bioimpedance Analyzers Market research report?

The forecast period in the Bioimpedance Analyzers Market research report is 2024-2032.

Who are the key players in Bioimpedance Analyzers Market?
What are the segments of the Bioimpedance Analyzers Market?
What is the Bioimpedance Analyzers Market?
How big is the Bioimpedance Analyzers Market?